Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Sept 2026 for Atrium Therapeutics, Inc., €53k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Brendan R. Winslow: trading record in brief
All filings by Brendan R. Winslow on record concern Atrium Therapeutics, Inc. The record holds 2 filings, for trades running from 20 April 2026 to 18 September 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 22 September 2026 with a share grant (€53k) in Atrium Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brendan R. Winslow
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6,742 shares@ US$8.95Common StockSEC:0001193125-26-397941:0
30,000 shares0Common StockSEC:0001193125-26-170960:0
2 of 2 declarations
